Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04860804 · ClinicalTrials.gov registry record · Phase 4

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

A Phase 4 study of Pain, sponsored by Antonios Likourezos.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT04860804: Completed Phase 4 study of Pain, sponsored by Antonios Likourezos.

NCT04860804 is a Phase 4 study of Pain that has completed, run by Antonios Likourezos. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04860804, a Phase 4 study of Pain, has completed, sponsored by Antonios Likourezos.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.

Conditions Studied

Interventions

  • DRUG Aspirin and Ketamine
  • DRUG Oral Ketamine

Study Locations (1)

New York

  • Maimonides Medical Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-04-22
Est. Completion 2021-12-31
Phase Phase 4

Sponsor

Antonios Likourezos

33 total trials

What the Registry Record Tells You About NCT04860804

The ClinicalTrials.gov registry entry for NCT04860804 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Aspirin and Ketamine is the first listed.

NCT04860804 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04860804 about?

NCT04860804 is a clinical study titled "A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain". Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painf...

What is the current status of trial NCT04860804?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2021-04-22. Estimated completion is 2021-12-31.

What conditions does trial NCT04860804 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT04860804?

The interventions under investigation include: Aspirin and Ketamine (DRUG), Oral Ketamine (DRUG).

Who is sponsoring clinical trial NCT04860804?

This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04860804 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.